Interpace Biosciences (IDXG) EBITDA (2010 - 2026)
Interpace Biosciences (IDXG) posted EBITDA of $448,000 for Q2 2026, compared with -$367,000 a year earlier and down 63.9% from the prior quarter.
Interpace Biosciences (IDXG) EBITDA (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA at Interpace Biosciences was $4.64 million, down 23.9% year-over-year; for FY2025, it came in at $4.51 million, down 46.4% from FY2024.
- In prior years, Interpace Biosciences' EBITDA was $8.41 million in FY2024 (+68.8%), $4.98 million in FY2023, -$1.06 million in FY2022 and -$962,000 in FY2021.
- Quarterly EBITDA has run from a low of -$1.12 million in Q2 2022 to a high of $2.7 million in Q2 2024 over five years.
- On a year-over-year basis, EBITDA increased in three of the last six quarters, with growth averaging 44.1%.
- The strongest year-over-year quarter for EBITDA in the past five years was Q4 2023, with growth of 282.8%; the weakest was Q3 2025, with a decline of 47.4%.
- According to Business Quant data, EBITDA for the three prior quarters was $1.24 million (Q1 2026), $1.7 million (Q4 2025) and $1.26 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 103.18 Bn | 99.19 Bn | - | 4.05 Bn |
| 2 | Natera | 57.81 Bn | 53.49 Bn | 485.19 Mn | -54.61 Mn |
| 3 | Labcorp Holdings | 26.94 Bn | 24.69 Bn | 1.11 Bn | 630.60 Mn |
| 4 | Quest Diagnostics | 26.85 Bn | 24.98 Bn | 1.03 Bn | 605.00 Mn |
| 5 | Guardant Health | 22.51 Bn | 18.57 Bn | 219.03 Mn | -119.56 Mn |
| 6 | Tenet Healthcare | 22.37 Bn | 11.37 Bn | - | 1.72 Bn |
| 7 | Fresenius Medical Care AG | 13.20 Bn | 5.15 Bn | 1.52 Bn | 956.64 Mn |
| 8 | BrightSpring Health Services | 12.39 Bn | 10.72 Bn | 492.75 Mn | 174.76 Mn |
| 9 | Encompass Health | 12.26 Bn | 11.92 Bn | - | 384.80 Mn |
| 10 | Interpace Biosciences | 180.06 Mn | 170.78 Mn | 5.65 Mn | 448,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 448,000.00 |
| Mar 31, 2026 | 1.24 Mn |
| Dec 31, 2025 | 1.71 Mn |
| Sep 30, 2025 | 1.27 Mn |
| Jun 30, 2025 | -352,000.00 |
| Mar 31, 2025 | 1.94 Mn |
| Dec 31, 2024 | 2.16 Mn |
| Sep 30, 2024 | 2.39 Mn |
| Jun 30, 2024 | 2.70 Mn |
| Mar 31, 2024 | 1.17 Mn |
| Dec 31, 2023 | 1.56 Mn |
| Sep 30, 2023 | 666,000.00 |
| Jun 30, 2023 | 1.59 Mn |
| Mar 31, 2023 | 1.21 Mn |
| Dec 31, 2022 | 423,000.00 |
| Sep 30, 2022 | -131,000.00 |
| Jun 30, 2022 | -1.10 Mn |
| Mar 31, 2022 | -186,000.00 |
| Dec 31, 2021 | -316,000.00 |
| Sep 30, 2021 | -396,000.00 |
Interpace Biosciences EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=IDXG&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "IDXG", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=IDXG&period=max&api_key=YOUR_API_KEY");
const data = await res.json();